Polaris(DE:PL6)
€60.10+1.18 (+2.00%)
DE:PL6
Polaris stock drug pipeline
€60.10
At close:+1.18 (+2.00%)
Polaris (PL6) Drug Pipeline
0 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Adi-Peg20 | Nonalcoholic Steatohepatitis (Nash) | Phase II | Recruiting | Study of ADI-PEG 20 Versus Placebo in Subjects With NASH | Jan 20, 2023 | ― |
| Adi Peg20 | Soft Tissue Sarcoma | Phase III | Recruiting | Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) | Dec 13, 2022 | ― |
| Adi-Peg20 | Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma | Phase III | Recruiting | Study of ADI-PEG 20 Versus Placebo in Subjects with High Arginine Level and Unresectable Hepatocellular Carcinoma | Apr 01, 2022 | ― |
| Temozolomide, Adi-Peg 20 | Glioblastoma Multiforme (Gbm) | Phase II | Active Not Recruiting | ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme | Sep 04, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Adi-Peg20 | Phase II | Nonalcoholic Steatohepatitis (Nash) | Recruiting | Study of ADI-PEG 20 Versus Placebo in Subjects With NASH | Jan 20, 2023 | ― |
| Adi Peg20 | Phase III | Soft Tissue Sarcoma | Recruiting | Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) | Dec 13, 2022 | ― |
| Adi-Peg20 | Phase III | Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma | Recruiting | Study of ADI-PEG 20 Versus Placebo in Subjects with High Arginine Level and Unresectable Hepatocellular Carcinoma | Apr 01, 2022 | ― |
| Temozolomide, Adi-Peg 20 | Phase II | Glioblastoma Multiforme (Gbm) | Active Not Recruiting | ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme | Sep 04, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Polaris Industries (DE:PL6) have in its pipeline
Polaris DE:PL6 is currently developing the following drugs: Adi-Peg20, Adi Peg20, Temozolomide, Adi-Peg 20. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

